Gastro Flashcards
Most common site H Pylori ulcers
Duodenum
Most common cause gastric ulcers
H Pylori
Most common manifestation NSAID induced ulcers
Gastric
Indications for gastric biopsy
Gastric ulcer
Irregular
> 2cm
Which medication can cause mid oesophageal ulcers
Doxycycline
NASH histology feature
Hepatocyte ballooning
Workup of Crohn’s
- Imaging
- Procedures
Imaging - MRE for all patients
Scopes - C scope if suspected colonic or terminal ileal disease
CI to capsule endoscopy in Crohn’s workup
Stricturing disease
F/U scopes for peptic ulcer disease
- Duodenal
- Gastric
Duodenal - not needed unless symptoms persist
Gastric - Indications:
- Persistent symptoms
- Big ulcer >3cm
- Unclear aetiology
- Suspicious - malignancy, ulcer, bleeding etc
Methane breath test for?
SIBO
Treatment of SIBO
rifaxamin
Cause of platypnoea and orthodexia in hepatopulmonary syndrome
Pulmonary arterial dilatation
Refeeding - what do you need to replace PRIOR to starting feeding
Thiamine - avoid precipitating acute thiamine deficiency (Wernicke’s)
How long can CDT remain positive for after treatment?
6 weeks
Pancreatitis - intervention with mortality benefit first 24 hrs
IV fluids
Pancreatitis scoring
Glasgow Imrie
PaO2 < 60
Age > 55
Neus > 15
Ca < 2
Renal - urea > 16
Albumin < 32
Sugar > 10
Condition causing increases risk squamous cell carcinoma oesophagus
Achalasia
Achalasia treatment for patient who is surgical candidate?
POEM (peroral endoscopic myotomy)
Heller myotomy
Oesophagectomy (last line)
Achalasia treatment for patient not surgical candidate
1st line - botulinum injection if able
CCB’s
Long acting nitrates
OGD features EoE
Longtiduinal furrows
White exudates
Concentric rings
Initial treatment for EoE
8 week PPI course
OR
Swallowed steroid.
2nd line treatments for EoE
Elemental/elimination diet
Dupilumab
Barrett’s -no dysplasia f/u
5 yearly surveillance scopes, sooner in symptoms
Barett’s low grade dysplasia
Repeat scope 6 months, if changes confirmed radiofrequency ablation
Barrett’s high grade dysplasia
Endoscopic mucosal resection/oesophagectomy
RFA to remaining Barrett’s
Significance of CagA protein in H Pylori
CagA positive
- higher rate of duodenal ulcers
- Higher rate of GI malignancy
Gene associated with diffuse type gastric adenocarcinoma
CDH1 (can be somatic, germline, imbalance)
Lobular breast cancer
Signet ring cell gastric cancer
Syndrome?
genetic defect?
Hereditary diffuse gastric cancer
Germline mutation in CDH1
Periodic acid schiff positive
Gram positive rod
Trophyrema whipplei - whipple’s disease
Chronic diarrhoea
Arthralgias
Cognitive dysfunction
Whipple’s disease
DDx for RF -ve migratory arthritis that doesn’t respond to immunosuppresson
Whipple’s disease
Coeliac disease testing
1st - Anti TTG IgA
If Anti-TTG IgA weakly positive, and do anti endomysial IgA (specific, but technically difficult)
In IgA deficiency:
- TTG - IgG
- Anti-DPG IgG
PPI therapy UGIB pre-scope- eveidence
Reduces high risk stigmata - no mortality/morbidity benefit
PPI 72 hours after UGIB ulcer. evidence
Improves re-bleeding, hospital LoS, mortality
High risk stigmata on scope (Forest classification) that need IP PPI
Bleeding or oozing (Forest 1a and 1b)
Visible vessel or large clot (2a and 2b)
1st line H Pylori
7-14 days ACE
Amoxi
Claritho
PPI
1st ine H Pylori pencillin immediate hypersensitivity
ACE but replace amox with Metro
2nd line therapy if failed eradication
Remove clarithromycin - 10% success rates
Triple - ACE but use levofloxacin instead of clarithro
Quadruple - PPI, bismuth, metro, doxycycline
Chronic watery diarrhoea 65 year old female
Microscopic colitis
Risk factors Collagenous colitis
NSAID use
Smoking
Treatment of collagenous colitis
Budenoside
Cholestyramine if budenoside fails
Zollinger Ellison Dx approach
Fasting gastrin and gastric pH
- Gastrin high, pH < 2 to be diagnostic
Equivocal - secretin stimulation test